Genetic variation in the choline O-acetyltransferase gene in depression and Alzheimer's disease: The VITA and Milano studies

Journal of Psychiatric Research

Volumn 45, Issue 9, 2011, Pages 1250-1256

  Grünblatt, Edna ^a,b,e   Reif, Andreas ^b   Jungwirth, Susanne ^a   Galimberti, Daniela ^c   Weber, Heike ^b   Scarpini, Elio ^c   Sauer, Cathrin ^b   Wichart, Ildiko ^a   Rainer, Michael K ^a   Huber, Klaus ^d   Danielczyk, Walter ^a   Tragl, Karl H ^a   Deckert, Jürgen ^b   Fischer, Peter ^a,d   Riederer, Peter ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d DANUBE HOSPITAL   (Austria)

^e UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Alzheimer's disease; Choline acetyltransferase; Dementia; Depression; Haplotype; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; CHOLINE ACETYLTRANSFERASE;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; DEPRESSION; FOLLOW UP; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR DEPRESSION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; AUSTRIA; CHOLINE O-ACETYLTRANSFERASE; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ITALY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 80051670545     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.03.017     Document Type: Article

References (39)

1. Ahn Jo S., Ahn K., Kim J.H., Kang B.H., Kim E., Jo I., Kim D.K. ApoE-epsilon 4-dependent association of the choline acetyltransferase gene polymorphisms (2384G>A and 1882G>A) with Alzheimer's disease. Clinica Chimica Acta 2006, 368:179-182.
2. Auld D.S., Kornecook T.J., Bastianetto S., Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Progress in Neurobiology 2002, 68:209-245.
3. Bacciottini L., Passani M.B., Mannaioni P.F., Blandina P. Interactions between histaminergic and cholinergic systems in learning and memory. Behavioural Brain Research 2001, 124:183-194.
4. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
5. Beelke M., Sannita W.G. Cholinergic function and dysfunction in the visual system. Methods & Findings in Experimental & Clinical Pharmacology 2002, 24(Suppl. D):113-117.
6. Benjamini Y., Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 1995, 57:289-300.
7. Bertram L. Alzheimer's disease genetics current status and future perspectives. International Review of Neurobiology 2009, 84:167-184.
8. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., et al. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000, 290:2302-2303.
9. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 2007, 39:17-23.
10. Chapman P.F., Falinska A.M., Knevett S.G., Ramsay M.F. Genes, models and Alzheimer's disease. Trends in Genetics 2001, 17:254-261.
11. Cook L.J., Ho L.W., Wang L., Terrenoire E., Brayne C., Evans J.G., et al. Candidate gene association studies of genes involved in neuronal cholinergic transmission in Alzheimer's disease suggests choline acetyltransferase as a candidate deserving further study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2005, 132:5-8.
12. Di Fede G., Catania M., Morbin M., Rossi G., Suardi S., Mazzoleni G., et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science 2009, 323:1473-1477.
13. Ertekin-Taner N., Graff-Radford N., Younkin L.H., Eckman C., Baker M., Adamson J., et al. Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 2000, 290:2303-2304.
14. Fischer P., Zehetmayer S., Jungwirth S., Weissgram S., Krampla W., Hinterberger M., et al. Risk factors for alzheimer dementia in a community-based birth cohort at the age of 75 years. Dementia and geriatric cognitive disorders 2008, 25:501-507.
15. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
16. Grünblatt E., Schlößer R., Fischer P., Fischer M.O., Li J., Koutsilieri E., et al. Oxidative stress related markers in the "VITA" and the centenarian projects. Neurobiology of Aging 2005, 26:429-438.
17. Grünblatt E., Zehetmayer S., Bartl J., Löffler C., Wichart I., Rainer M.K., et al. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study. Journal of Psychiatric Research 2008.
18. Harold D., Macgregor S., Patterson C.E., Hollingworth P., Moore P., Owen M.J., et al. A single nucleotide polymorphism in CHAT influences response to acetylcholinesterase inhibitors in Alzheimer's disease. Pharmacogenetics and Genomics 2006, 16:75-77.
19. Harold D., Peirce T., Moskvina V., Myers A., Jones S., Hollingworth P., et al. Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. Human Genetics 2003, 113:258-267.
20. Kamboh M.I. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 2004, 68:381-404.
21. Kim K.W., Suh Y.J., Park W.Y., Jhoo J.H., Lee D.Y., Youn J.C., et al. Choline acetyltransferase G +4 A polymorphism confers a risk for Alzheimer's disease in concert with Apolipoprotein E epsilon4. Neuroscience Letters 2004, 366:182-186.
22. Laws S.M., Hone E., Gandy S., Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. Journal of Neurochemistry 2003, 84:1215-1236.
23. Li Y.J., Scott W.K., Hedges D.J., Zhang F., Gaskell P.C., Nance M.A., et al. Age at onset in two common neurodegenerative diseases is genetically controlled. The American Journal of Human Genetics 2002, 70:985-993.
24. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984, 34:939-944.
25. Menashe I., Rosenberg P.S., Chen B.E. PGA: power calculator for case-control genetic association analyses. BMC Genet 2008, 9:36.
26. Mubumbila V., Sutter A., Ptok U., Heun R., Quirin-Stricker C. Identification of a single nucleotide polymorphism in the choline acetyltransferase gene associated with Alzheimer's disease. Neuroscience Letters 2002, 333:9-12.
27. Mufson E.J., Counts S.E., Fahnestock M., Ginsberg S.D. Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Current Alzheimer Research 2007, 4:340-350.
28. Mufson E.J., Ginsberg S.D., Ikonomovic M.D., DeKosky S.T. Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. The Journal of Chemical Neuroanatomy 2003, 26:233-242.
29. Myers A., Wavrant De-Vrieze F., Holmans P., Hamshere M., Crook R., Compton D., et al. Full genome screen for Alzheimer disease: stage II analysis. American Journal of Medical Genetics 2002, 114:235-244.
30. Naarding P., Leentjens A.F., van Kooten F., Verhey F.R. Disease-specific properties of the Rating Scale for Depression in patients with stroke, Alzheimer's dementia, and Parkinson's disease. The Journal of Neuropsychiatry and Clinical Neurosciences 2002, 14:329-334.
31. Oda Y. Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system. Pathology International 1999, 49:921-937.
32. Ozturk A., DeKosky S.T., Kamboh M.I. Genetic variation in the choline acetyltransferase (CHAT) gene may be associated with the risk of Alzheimer's disease. Neurobiology of Aging 2006, 27:1440-1444.
33. Piccardi M., Congiu D., Squassina A., Manconi F., Putzu P.F., Mereu R.M., et al. Alzheimer's disease: case-control association study of polymorphisms in ACHE, CHAT, and BCHE genes in a Sardinian sample. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2007.
34. R Development Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2008. http://www.R-project.org/.
35. Scacchi R., Gambina G., Moretto G., Corbo R.M. Variability of AChE, BChE, and ChAT genes in the late-onset form of Alzheimer's disease and relationships with response to treatment with Donepezil and Rivastigmine. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2009, 150B:502-507.
36. Schwarz S., Eisele T., Diehl J., Muller U., Forstl H., Kurz A., Riemenschneider M. Lack of association between a single nucleotide polymorphism within the choline acetyltransferase gene and patients with Alzheimer's disease. Neuroscience Letters 2003, 343:167-170.
37. Selden N.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998, 121(Pt 12):2249-2257.
38. Serretti A., Olgiati P., De Ronchi D. Genetics of Alzheimer's disease. A rapidly evolving field. Journal of Alzheimer's disease 2007, 12:73-92.
39. Tang M., Rao D., Ma C., Guo Y., Han H., Ling K., Ling Y. Evaluation of choline acetyltransferase gene polymorphism (2384 G/A) in Alzheimer's disease and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders 2008, 26:9-14.